Retatrutide is an investigational 39-amino-acid, fatty-acid-acylated triple agonist engineered to engage the GIP, GLP-1, and glucagon receptors from a single peptide backbone
Knowing your genetic profile in these pathways can support a more informed conversation with your provider about formulation choice, dosing strategy, and potential side effect risk
Research has demonstrated no significant changes in fasting glucose or insulin sensitivity in subjects using the peptide
While Clomid is generally considered to be safe, as with almost every drug, there are some side effects
Your One Life plan will be as unique as you are
Emotional and Behavioral Changes to Watch For In recent years, GLP-1s have become some of the most talked about medications in the medical community